Now showing items 1-2 of 2

    • Copy Number Profiling of Brazilian Astrocytomas. 

      Bidinotto, LT; Torrieri, R; Mackay, A; Almeida, GC; Viana-Pereira, M; Cruvinel-Carloni, A; Spina, ML; Campanella, NC; Pereira de Menezes, W; Clara, CA; Becker, AP; Jones, C; Reis, RM (2016-07-07)
      Copy number alterations (CNA) are one of the driving mechanisms of glioma tumorigenesis, and are currently used as important biomarkers in the routine setting. Therefore, we performed CNA profiling of 65 astrocytomas of ...
    • Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial. 

      Bisogno, G; De Salvo, GL; Bergeron, C; Gallego Melcón, S; Merks, JH; Kelsey, A; Martelli, H; Minard-Colin, V; Orbach, D; Glosli, H; Chisholm, J; Casanova, M; Zanetti, I; Devalck, C; Ben-Arush, M; Mudry, P; Ferman, S; Jenney, M; Ferrari, A; European paediatric Soft tissue sarcoma Study Group (2019-11)
      BACKGROUND:For more than three decades, standard treatment for rhabdomyosarcoma in Europe has included 6 months of chemotherapy. The European paediatric Soft tissue sarcoma Study Group (EpSSG) aimed to investigate whether ...